Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity

Baker JF, Hensor EMA, Mikuls TR, Wysham KD, England BR, Barton JL, Schwab P, Cannon GW, Sauer B, Kunkel G, Riley T 4th, Quinones M, Kerr G, Smith ID, Danila MI, Richards JS, Razmjou A, Wallace B, George MD, O'Dell JR, Maldonado MA, Møller-Bisgaard S, Hørslev-Petersen K, Georgiadis S, Smolen JS, Emery P, Aletaha D, Østergaard M, Conaghan PG. Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity. Ann Rheum Dis. 2026 Nov 12:S0003-4967(26)03776-3. doi: 10.1016/j.ard.2026.10.3165. Epub ahead of print. PMID: 43020702.


Related Posts